Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Developing national guidance on genetic testing for breast cancer predisposition: the role of economic evidence?

Genetic testing and molecular biomarkers - 1 Jun 2012

Sullivan William, Evans D Gareth, Newman William G, Ramsden Simon C, Scheffer Hans, Payne Katherine

Abstract excerpt

Advancements in genetic testing to identify predisposition for hereditary breast cancer (HBC) mean that it is important to understand the incremental costs and benefits of the new technologies compared with current testing strategies. This study aimed to (1) identify and critically appraise existing economic evidence for BRCA1/2 mutation testing for HBC and (2) establish whether economic evidence was used to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to England

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Health Policy

Share to Interviews as Topic

Share to Practice Guidelines as Topic

Source

Identifiers

PMID: 22313048
DOI: 10.1089/gtmb.2011.0236

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Developing national guidance on genetic testing for breast cancer predisposition: the role of economic evidence?PMID 22313048Read ↗

Genetic testing and economic evaluations: a systematic review of the literature.Semantic proximity Read ↗

Cancer genetics services: a systematic review of the economic evidence and issues.Semantic proximity Read ↗

Genetic screening by DNA technology: a systematic review of health economic evidence.Semantic proximity Read ↗

Cost-effectiveness of testing for breast cancer susceptibility genes.Semantic proximity Read ↗

Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.Semantic proximity Read ↗

Cost-effectiveness of Universal BRCA1/2 Screening: Evidence-Based Decision Making.Semantic proximity Read ↗

Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation.Semantic proximity Read ↗

Can we really afford to spend NHS cash on genetic testing for cancer?Semantic proximity Read ↗

A cost analysis of a cancer genetic service model in the UKSemantic proximity Read ↗

The use of gene tests to detect hereditary predisposition to chronic disease: is cost-effectiveness analysis relevant?Semantic proximity Read ↗

Estimated Cost-effectiveness of Genetic Testing in Siblings of Newborns With Cancer Susceptibility Gene Variants.Semantic proximity Read ↗

Preferences for Genetic Testing to Predict the Risk of Developing Hereditary Cancer: A Systematic Review of Discrete Choice Experiments.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.